| 2023-07-07 | Sale | FibroGen, Inc. FGEN | Chief Executive Officer | 1,880 0.0021% | $2.80 | $5,264 | -57.78% | |
| 2023-06-07 | Sale | FibroGen, Inc. FGEN | Chief Executive Officer | 8,897 0.0093% | $17.04 | $151,583 | -92.99% | |
| 2023-04-10 | Sale | FibroGen, Inc. FGEN | Chief Executive Officer | 1,869 0.002% | $19.52 | $36,483 | -91.09% | |
| 2023-03-10 | Sale | FibroGen, Inc. FGEN | Chief Executive Officer | 19,489 0.0207% | $20.20 | $393,625 | -91.15% | |
| 2023-03-08 | Sale | FibroGen, Inc. FGEN | Chief Executive Officer | 24,672 0.0262% | $21.16 | $521,958 | -91.44% | |
| 2023-01-06 | Sale | FibroGen, Inc. FGEN | Chief Executive Officer | 1,538 0.0016% | $19.95 | $30,683 | -86.51% | |
| 2022-12-08 | Sale | FibroGen, Inc. FGEN | Chief Executive Officer | 2,543 0.0029% | $15.79 | $40,154 | +1.43% | |
| 2020-06-11 | FibroGen, Inc. FGEN | Chief Executive Officer | 19,800 0.0223% | $35.28 | $698,599 | +18.06% | ||
| 2020-06-10 | FibroGen, Inc. FGEN | Chief Executive Officer | 8,000 0.0087% | $36.29 | $290,282 | +10.9% | ||
| 2019-02-15 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 50,000 0.005% | $121.00 | $6.05M | -4.84% | |
| 2018-05-31 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 50,000 0.0049% | $85.00 | $4.25M | +34.13% | |
| 2017-05-04 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 50,000 0.0045% | $82.76 | $4.14M | -0.04% | |
| 2015-12-09 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 25,000 0.0023% | $83.88 | $2.1M | -6.51% | |
| 2014-11-03 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 5,000 0.0004% | $66.03 | $330,150 | +12.28% | |
| 2014-10-01 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 5,000 0.0004% | $64.86 | $324,300 | +12.62% | |
| 2014-09-02 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 5,000 0.0004% | $63.60 | $318,000 | +13.94% | |
| 2014-07-25 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 10,000 0.0009% | $63.79 | $637,900 | +12.83% | |
| 2013-08-15 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 5,000 0.0004% | $53.79 | $268,950 | +5.31% | |
| 2013-07-15 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 5,000 0.0004% | $51.43 | $257,150 | +5.27% | |
| 2013-06-17 | Sale | Eli Lilly and Company LLY | SVP&Pres, LillyDiab & LillyUSA | 5,000 0.0004% | $52.45 | $262,250 | +1.94% |